docetaxel anhydrous has been researched along with Genital Neoplasms, Female in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 6 (31.58) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mahdi, H; Maurer, K; Michener, C; Rose, PG | 1 |
| Amano, H; Onishi, M; Tsunoda, K; Watanabe, A | 1 |
| Hosoda, Y; Inoue, K; Ito, K; Kanazawa, R; Miyagi, Y; Shibahara, H; Takeuchi, S; Toyoda, S; Tsubamoto, H | 1 |
| Kamimura, K; Matsumoto, Y; Moriyama, M; Saijo, Y; Zhou, Q | 1 |
| Huang, CQ; Ji, ZH; Li, Y; Peng, KW; Sun, JH; Wu, HT; Yang, XJ; Zhang, Q | 1 |
| Kendrick, JE; Kilgore, LC; Matthews, KS; Numnum, TM; Shipman, KA; Straughn, JM; Whitworth, JM | 1 |
| Aissi, M; Kubis, N; Lévy, BI; Milani, P; Osmani, K; Vignes, S; Wade, F | 1 |
| Callahan, MJ; Reeves, DJ; Sutton, GP | 1 |
| Fujii, H; Ishitani, K; Kamatani, N; Kanno, H; Matsui, H; Ohta, H; Saito, K; Uchiyama, T | 1 |
| Bast, RC; Berek, JS; Bookman, MA; Cannistra, SA; Crum, CP; DePriest, PD; Garber, JE; King, L; Koh, WJ; Markman, M; McGuire, WP; Rose, PG; Rowinsky, EK; Rustin, GJ; Skates, SJ; Vasey, PA | 1 |
| Belinson, J; Kulp, B; Markman, J; Markman, M; Peterson, G; Webster, K; Zanotti, K | 1 |
| Blohmer, JU; du Bois, A; Hilpert, F; Pfisterer, J; Quaas, J; Wagner, U; Wallwiener, D | 1 |
| Castells, M; Feldweg, AM; Lee, CW; Matulonis, UA | 1 |
| Disilvestro, P; Dizon, DS; Gordinier, ME; Granai, CO; Legare, RD; Miller, J; Moore, R; Pires, L; Rojan, A; Schwartz, J | 1 |
| Hepp, H; Konecny, G; Korell, M; Nestle-Krämling, C; Sevin, BU; Untch, A; Untch, M | 1 |
| Angioli, R; Averette, HE; Koechli, O; Perras, JP; Sevin, BU; Untch, A; Untch, M | 1 |
| Sugiyama, T; Ushijima, K; Yakushiji, M | 1 |
| Armand, JP; Couteau, C | 1 |
| Cabral, F; Reed, E; Sarosy, G; Trimble, E | 1 |
3 review(s) available for docetaxel anhydrous and Genital Neoplasms, Female
| Article | Year |
|---|---|
[Promising new drugs for gynecological cancer].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Clinical Trials, Phase I as Topic; Cyclophosphamide; Docetaxel; Drug Administration Schedule; Female; Genital Neoplasms, Female; Humans; Irinotecan; Organoplatinum Compounds; Paclitaxel; Taxoids; Topotecan | 1997 |
[Irinotecan-containing combinations in solid tumors, except colonic carcinomas].
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Diarrhea; Docetaxel; Enzyme Inhibitors; Etoposide; Female; Genital Neoplasms, Female; Humans; Irinotecan; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Neoplasm Proteins; Neoplasms; Neutropenia; Paclitaxel; Stomach Neoplasms; Taxoids; Topoisomerase I Inhibitors; Treatment Outcome | 1998 |
Future directions with taxane therapy.
Topics: Antineoplastic Agents, Phytogenic; Docetaxel; Female; Genital Neoplasms, Female; Humans; Paclitaxel; Taxoids | 1999 |
3 trial(s) available for docetaxel anhydrous and Genital Neoplasms, Female
| Article | Year |
|---|---|
Feasibility and efficacy of intraperitoneal docetaxel administration as salvage chemotherapy for malignant gynaecological ascites.
Topics: Adenocarcinoma, Clear Cell; Aged; Antineoplastic Agents; Ascites; Docetaxel; Feasibility Studies; Female; Genital Neoplasms, Female; Humans; Infusions, Parenteral; Middle Aged; Retrospective Studies; Salvage Therapy; Taxoids | 2015 |
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy with lobaplatin and docetaxel improves survival for patients with peritoneal carcinomatosis from abdominal and pelvic malignancies.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Chemotherapy, Cancer, Regional Perfusion; Cyclobutanes; Cytoreduction Surgical Procedures; Docetaxel; Drug Synergism; Feasibility Studies; Female; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Male; Middle Aged; Organoplatinum Compounds; Peritoneal Neoplasms; Survival Rate; Taxoids; Treatment Outcome | 2016 |
Docetaxel and carboplatin as first-line chemotherapy in patients with advanced gynecological tumors. A phase I/II trial of the Arbeitsgemeinschaft Gynäkologische Onkologie (AGO-OVAR) Ovarian Cancer Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cohort Studies; Docetaxel; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Taxoids | 2004 |
13 other study(ies) available for docetaxel anhydrous and Genital Neoplasms, Female
| Article | Year |
|---|---|
Universal tolerance of nab-paclitaxel for gynecologic malignancies in patients with prior taxane hypersensitivity reactions.
Topics: Adult; Aged; Albumins; Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Drug Hypersensitivity; Female; Gemcitabine; Genital Neoplasms, Female; Humans; Middle Aged; Nervous System Diseases; Neutropenia; Paclitaxel; Retreatment; Retrospective Studies; Taxoids; Thrombocytopenia | 2017 |
Meningeal Carcinomatosis in Advanced Extramammary Paget's Disease: A Case Report.
Topics: Aged; Antineoplastic Agents; Bone Neoplasms; Cranial Irradiation; Docetaxel; Female; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Meningeal Carcinomatosis; Paget Disease, Extramammary; Spinal Puncture; Treatment Outcome | 2019 |
Myelosuppression by chemotherapy in obese patients with gynecological cancers.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Carboplatin; Docetaxel; Dose-Response Relationship, Drug; Female; Genital Neoplasms, Female; Hematologic Diseases; Humans; Ideal Body Weight; Japan; Middle Aged; Obesity; Paclitaxel; Retrospective Studies; Taxoids; Thinness; Young Adult | 2016 |
The safety and efficacy of day 1 versus day 2 administration of pegfilgrastim in patients receiving myelosuppressive chemotherapy for gynecologic malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Drug Administration Schedule; Female; Filgrastim; Genital Neoplasms, Female; Granulocyte Colony-Stimulating Factor; Humans; Middle Aged; Neutropenia; Paclitaxel; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Taxoids; Young Adult | 2009 |
Taxane-induced peripheral neuropathy has good long-term prognosis: a 1- to 13-year evaluation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Docetaxel; Electromyography; Evoked Potentials, Motor; Female; Genital Neoplasms, Female; Humans; Longitudinal Studies; Middle Aged; Neural Conduction; Neurologic Examination; Paclitaxel; Peripheral Nerves; Peripheral Nervous System Diseases; Taxoids; Time Factors | 2012 |
Successful desensitization to docetaxel after severe hypersensitivity reactions in two patients.
Topics: Adult; Antineoplastic Agents; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Middle Aged; Severity of Illness Index; Taxoids; Treatment Outcome | 2012 |
An SNP in CYP39A1 is associated with severe neutropenia induced by docetaxel.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Docetaxel; Female; Genital Neoplasms, Female; Genotype; Humans; Middle Aged; Neutropenia; Polymorphism, Single Nucleotide; Steroid Hydroxylases; Taxoids | 2012 |
Progress in the management of gynecologic cancer: consensus summary statement.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biological Products; Carcinoma; Combined Modality Therapy; Docetaxel; Drugs, Investigational; Female; Genital Neoplasms, Female; Humans; Immunotherapy; Infusions, Parenteral; Injections, Intraperitoneal; Mass Screening; Organoplatinum Compounds; Ovarian Neoplasms; Predictive Value of Tests; Taxoids; Treatment Outcome; Uterine Cervical Neoplasms | 2003 |
Experience with the management of neutropenia in gynecologic cancer patients receiving carboplatin-based chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Docetaxel; Female; Fever; Genital Neoplasms, Female; Humans; Middle Aged; Neutropenia; Paclitaxel; Retrospective Studies; Taxoids | 2004 |
Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Desensitization, Immunologic; Docetaxel; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Middle Aged; Paclitaxel; Taxoids | 2005 |
Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Docetaxel; Drug Hypersensitivity; Female; Genital Neoplasms, Female; Humans; Paclitaxel; Retrospective Studies; Taxoids | 2006 |
[Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
Topics: Adenosine Triphosphate; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cell Line; Cell Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Genital Neoplasms, Female; Humans; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1993 |
Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
Topics: Adenocarcinoma; Adenosine Triphosphate; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Survival; Docetaxel; Drug Resistance; Drug Screening Assays, Antitumor; Female; Genital Neoplasms, Female; Humans; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1994 |